These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 13648321)
21. [Cardiac action of the active constituents of Crataegus]. WEZLER K Arzneimittelforschung; 1958 Apr; 8(4):175-81. PubMed ID: 13535346 [No Abstract] [Full Text] [Related]
22. [Significance of the change of lactic and pyruvic acid levels of the blood in cardiac decompensation]. ANTALOCZY Z; BRETAN M; LOVEI E Wien Klin Wochenschr; 1956 May; 68(20):387-91. PubMed ID: 13353038 [No Abstract] [Full Text] [Related]
23. [The effect of a Crataegus effective substance on the heart and the blood circulation (heptaoxyflavanglykosid)]. HILLE H; SCHAEFER H; TESKE HJ; ZIPF KE Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 227(3):281-92. PubMed ID: 13309425 [No Abstract] [Full Text] [Related]
24. [Contribution to the therapy of the failing heart in the aged and postapoplectic dementia]. STABENOW U Med Klin; 1962 Aug; 57():1495-7. PubMed ID: 13978632 [No Abstract] [Full Text] [Related]
25. [HEART TREATMENT IN RESTRICTED LUNG FUNCTION]. WILDE W Med Monatsschr; 1964 Feb; 18():78-80. PubMed ID: 14165995 [No Abstract] [Full Text] [Related]
26. Hawthorn--Crataegus monogyna (common hawthorn) or Crataegus laevigata (midland hawthorn; Crataegus oxyacantha); also known as haw, thornapple, maythorn, whitethorn. Rasmussen P J Prim Health Care; 2011 Mar; 3(1):63-4. PubMed ID: 21359265 [No Abstract] [Full Text] [Related]
27. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial. Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M; Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730 [TBL] [Abstract][Full Text] [Related]
28. [Contribution on the question of a coronary effect of aqueous extracts of Crataegus]. HOCKERTS T; MULKE G Arzneimittelforschung; 1955 Dec; 5(12):755-7. PubMed ID: 13293086 [No Abstract] [Full Text] [Related]
29. [Effect of cocarboxylase on blood pyruvic acid in cardiac decompensation and digitalis intoxication]. BENDA L; DONEFF D; MOSER K Z Kreislaufforsch; 1958 Mar; 47(5-6):237-45. PubMed ID: 13558377 [No Abstract] [Full Text] [Related]
30. [Problem of the experimental determination of cardiac effectiveness of Crataegus]. LUBBERS F; KUSCHKE HJ Arzneimittelforschung; 1955 Oct; 5(10):603-4. PubMed ID: 13276295 [No Abstract] [Full Text] [Related]
34. [Observations in intermediary metabolism in heart failure]. GITELSON S Harefuah; 1954 Aug; 47(3):50-3. PubMed ID: 13191720 [No Abstract] [Full Text] [Related]
35. [Ambulant cardiac therapy with the digitalis-Crataegus combination lanatacanth]. MANNHARDT MG Med Klin; 1958 May; 53(18):801-2. PubMed ID: 13551832 [No Abstract] [Full Text] [Related]
36. [Cardiac disorders in children with special reference to Crataegus therapy]. WEINER E Kinderarztl Prax; 1956 Dec; 24(12):541-4. PubMed ID: 13406959 [No Abstract] [Full Text] [Related]
37. Clinical experience in therapy of heart diseases with Crataegus. STIRN A Medizinische; 1954 Dec; 49():1651-3. PubMed ID: 13235147 [No Abstract] [Full Text] [Related]
38. [Effect of Crataegus, digitalis and strophanthin on lactic acid in the blood]. ULLSPERGER R Pharmazie; 1954 Apr; 9(4):330-5. PubMed ID: 13177159 [No Abstract] [Full Text] [Related]
39. [The effect of the aqueous solution of an active principle, heptahydroxyflavanglycoside, from Crataegus on the heart and circulation in dogs]. ENGELKING R; WILLIG F Arzneimittelforschung; 1958 Jan; 8(1):39-42. PubMed ID: 13510154 [No Abstract] [Full Text] [Related]
40. [Crataegus special extract WS 1442 in the treatment of early stages of CHD-associated heart failure]. Koller M; Lorenz W; Aubke W; Jensen A; Gerlach FM; Kuhl J; Pfeil T; Regitz-Zagrosek V; Rusche H; Rychlik R MMW Fortschr Med; 2006 Feb; 148(6):42. PubMed ID: 16526340 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]